Press releases

20
Nov 2019
21:30 E.S.T.

Cellectis Wins Patent Challenge in Europe for a Method Using CRISPR-Cas9 for Gene Editing in T-Cells

Read more
13
Nov 2019
21:30 E.S.T.

Cellectis Publishes Creation of “Smart CAR T-Cells” for Potentially Safer, More Effective Treatments for Cancer in Nature Communications

Read more
6
Nov 2019
21:47 E.S.T.

Cellectis Reports Financial Results for Third Quarter and First Nine Months 2019

Read more
31
Oct 2019
20:30 E.S.T.

Cellectis to Hold Third Quarter and First Nine Months 2019 Earnings Call on Thursday, November 7, 2019 at 8:00 AM EST

Read more
30
Oct 2019
20:30 E.S.T.

The Institut Pasteur and Cellectis extend exclusive license rights by granting genOway the authority to take action against infringement

Read more
29
Oct 2019
20:30 E.S.T.

First Patient Dosed with Off-the-Shelf UCARTCS1 Product Candidate for Relapsed/Refractory Multiple Myeloma

Read more
1
Oct 2019
20:30 E.S.T.

Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates

Read more
6
Aug 2019
20:30 E.S.T.

Cellectis Reports Financial Results for Second Quarter and First Six Months 2019

Read more
8
Jul 2019
20:30 E.S.T.

Cellectis Publishes New CAR Design to Control CAR T-Cells in Non-Lethal Way

Read more
26
Jun 2019
20:30 E.S.T.

Cellectis S.A. Reports Results from Combined Shareholders Meeting Held on June 25, 2019

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US